欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号
DE/H/2631/008
药品名称
L-Thyroxin-Na-CT 200 Mikrogramm Tabletten
活性成分
Levothyroxine sodium 200.0 µg
剂型
Tablet
上市许可持有人
AbZ-Pharma GmbH Graf-Arco-Str. 3 89079 Ulm Germany
参考成员国 - 产品名称
Germany (DE)
L-Thyroxin Teva 200 mcg, Tabletten
互认成员国 - 产品名称
Netherlands (NL)
Portugal (PT)
Italy (IT)
许可日期
2012/10/28
最近更新日期
2025/10/14
药物ATC编码
H03AA01 levothyroxine sodium
申请类型
TypeLevel1：
Abridged
TypeLevel2：
Additional Strength/Form
TypeLevel3：
Generic
TypeLevel4：
Chemical Substance
TypeLevel5：
Prescription Only
附件文件下载
Final SPC
|
levothyroxine_de_h_2631_001_008_smpc_06_05_24
Date of last change:2024/12/17
Final PL
|
levothyroxine_de_h_2631_001_008_pil_06_05_24
Date of last change:2024/12/17
PubAR
|
04_DE2631_DE3043_01_08_L_Thyroxin_final PAR
Date of last change:2024/09/06
Final Labelling
|
1_3_1 label immediate blisters Levothyroxine Sodium 0_025mg
Date of last change:2024/09/06
Final Labelling
|
1_3_1 label immediate blisters Levothyroxine Sodium 0_050mg
Date of last change:2024/09/06
Final Labelling
|
1_3_1 label immediate blisters Levothyroxine Sodium 0_075mg
Date of last change:2024/09/06
Final Labelling
|
1_3_1 label immediate blisters Levothyroxine Sodium 0_100mg
Date of last change:2024/09/06
Final Labelling
|
1_3_1 label immediate blisters Levothyroxine Sodium 0_125mg
Date of last change:2024/09/06
Final Labelling
|
1_3_1 label immediate blisters Levothyroxine Sodium 0_150mg
Date of last change:2024/09/06
Final Labelling
|
1_3_1 label immediate blisters Levothyroxine Sodium 0_175mg
Date of last change:2024/09/06
Final Labelling
|
1_3_1 label immediate blisters Levothyroxine Sodium 0_200mg
Date of last change:2024/09/06
Final Product Information
|
common_final_pl_2631_V015G
Date of last change:2024/09/06
Final Product Information
|
common_final_spc_2631_V015G
Date of last change:2024/09/06
市场状态
Positive
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase